** = Publikationen gelistet in SCI/SSCI/Pubmed
** Dalpiaz, O; Ehrlich, GC; Mannweiler, S; Hernández, JM; Gerger, A; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M; Hutterer, GC
Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
BJU Int. 2014; 114(3):334-339
Doi: 10.1111/bju.12441
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Dalpiaz, O; Pichler, M; Mannweiler, S; Martín Hernández, JM; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC
Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
Br J Cancer. 2014; 110(10):2531-2536
Doi: 10.1038/bjc.2014.180
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pichler, M; Dalpiaz, O; Ehrlich, GC; Stojakovic, T; Martín Hernández, JM; Mannweiler, S; Pummer, K; Zigeuner, R; Hutterer, GC
Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinoma.
J Urol. 2014; 191(4):920-925
Doi: 10.1016/j.juro.2013.10.073
Web of Science
PubMed
FullText
FullText_MUG
** Hutterer, GC; Stoeckigt, C; Stojakovic, T; Hernandez, JMM; Eberhard, K; Mannweiler, S; Gerger, A; Pummer, K; Pichler, M; Zigeuner, R
High preoperative monocyte-lymphocyte ratio (MLR) as a prognostic factor in nonmetastatic clear cell renal cell carcinoma.
J CLIN ONCOL. 2014; 32(4):
Doi: 10.1200/jco.2014.32.4_suppl.534
[Poster]
Web of Science
FullText
FullText_MUG